QOF database

Home | News | Downloads
Abertawe Bro Morgannwg University Health Board > BRIDGEND GROUP

BRIDGEND GROUP

MERTHYR MAWR ROAD, BRIDGEND

HF004W

In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta-blocker licensed for heart failure.

IndicatorYearNumeratorDenominatorRatioCentile
HF 4 2010 43 57 75.4%
HF 4 2011 43 55 78.2%
HF 4 2012 40 53 75.5%
HF 4 2013 38 50 76.0%
HF004W 2014 8 8 100.0%
HF004 2015 9 12 75.0%